(Q44901078)

English

Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.

scientific article

Statements

Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3. (English)
Prince George
Purva Bali
Pamela Cohen
Jianguo Tao
Celia Sigua
Anasuya Vishvanath
Warren Fiskus
Anna Scuto
Srinivas Annavarapu
Lynn Moscinski
Kapil Bhalla
3645-3652

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit